FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Isabell Herrmann

Research Profile

Living Beings

Procedures

Physiology

Virus Replication

Chemicals & Drugs

Anatomy

Disorders

Co-author Network

Publications

TOP 3
Mariam A Stoff-Khalili; Angel A Rivera; Alexander Stoff; J Michael Mathis; Rodney P Rocconi; Qiana L Matthews; Michael T Numnum; Isabell Herrmann; Peter Dall; Devin E Eckhoff; Joanne T Douglas; Gene P Siegal; Zeng B Zhu; David T Curiel
Combining high selectivity of replication via CXCR4 promoter with fiber chimerism for effective adenoviral oncolysis in breast cancer.
Martina Breidenbach; Daniel T Rein; Thomas Schöndorf; Kiran N Khan; Isabell Herrmann; Torsten Schmidt; Paul N Reynolds; Israel Vlodavsky; Yosef S Haviv; David T Curiel
A new targeting approach for breast cancer gene therapy using the heparanase promoter.
Gerd J Bauerschmitz; Kilian Guse; Anna Kanerva; Artur Menzel; Isabell Herrmann; Renee A Desmond; Masato Yamamoto; Dirk M Nettelbeck; Tanja Hakkarainen; Peter Dall; David T Curiel; Akseli Hemminki
Triple-targeted oncolytic adenoviruses featuring the cox2 promoter, E1A transcomplementation, and serotype chimerism for enhanced selectivity for ovarian cancer cells.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Isabell Herrmann (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Mariam A Stoff-Khalili; Angel A Rivera; Alexander Stoff; J Michael Mathis; Rodney P Rocconi; Qiana L Matthews; Michael T Numnum; Isabell Herrmann; Peter Dall; Devin E Eckhoff; Joanne T Douglas; Gene P Siegal; Zeng B Zhu; David T Curiel
Combining high selectivity of replication via CXCR4 promoter with fiber chimerism for effective adenoviral oncolysis in breast cancer.
International journal of cancer. Journal international du cancer 2007;120(4):935-41.
2006: Martina Breidenbach; Daniel T Rein; Thomas Schöndorf; Kiran N Khan; Isabell Herrmann; Torsten Schmidt; Paul N Reynolds; Israel Vlodavsky; Yosef S Haviv; David T Curiel
A new targeting approach for breast cancer gene therapy using the heparanase promoter.
Cancer letters 2006;240(1):114-22.
2006: Gerd J Bauerschmitz; Kilian Guse; Anna Kanerva; Artur Menzel; Isabell Herrmann; Renee A Desmond; Masato Yamamoto; Dirk M Nettelbeck; Tanja Hakkarainen; Peter Dall; David T Curiel; Akseli Hemminki
Triple-targeted oncolytic adenoviruses featuring the cox2 promoter, E1A transcomplementation, and serotype chimerism for enhanced selectivity for ovarian cancer cells.
Molecular therapy : the journal of the American Society of Gene Therapy 2006;14(2):164-74.
2005: Peter Dall; Isabell Herrmann; Bettina Durst; Mariam A Stoff-Khalili; Gerd J Bauerschmitz; Bettina Hanstein; Dieter Niederacher
In vivo cervical cancer growth inhibition by genetically engineered cytotoxic T cells.
Cancer immunology, immunotherapy : CII 2005;54(1):51-60.
2004: Gerd J Bauerschmitz; Anna Kanerva; Minghui Wang; Isabell Herrmann; Denise R Shaw; Theresa V Strong; Renee A Desmond; Daniel T Rein; Peter Dall; David T Curiel; Akseli Hemminki
Evaluation of a selectively oncolytic adenovirus for local and systemic treatment of cervical cancer.
International journal of cancer. Journal international du cancer 2004;111(2):303-9.